IFNA1 and Miyoshi myopathy: In particular, these data suggested compromised immune activation might be induced by impairment of MHC class I/IFN-mediated immunosurveillance, which supporting the observations from triple-refractory MM patients [43], and indicated that under treatment pressure, myeloma cells responded at an early timepoint to escape from immune system for its survival and subsequent resistance.